What is the best cream to incorporate polymeric nanocapsules for atopic dermatitis?
Best insight from top research papers
Polymeric nanocapsules have been investigated for the topical treatment of atopic dermatitis (AD) in several studies. Different formulations have been proposed, including polymeric nanoparticles , gellan gum/pullulan bilayer film containing silibinin-loaded nanocapsules , and tacrolimus-loaded poly(e-caprolactone) (PCL) nanocapsules . Additionally, levocetirizine-loaded polymeric nanoparticles and niosomal formulations have also been studied . Each of these formulations has shown promising results in terms of skin penetration, drug release, and therapeutic efficacy. However, it is important to note that the "best" cream to incorporate polymeric nanocapsules for atopic dermatitis may depend on various factors such as the specific drug being delivered, desired release profile, and patient-specific characteristics. Further research and comparative studies are needed to determine the optimal formulation for polymeric nanocapsules in the treatment of atopic dermatitis.
Answers from top 5 papers
More filters
| Papers (5) | Insight |
|---|---|
| The paper does not mention the best cream to incorporate polymeric nanocapsules for atopic dermatitis. The paper focuses on comparing levocetirizine loaded polymeric nanoparticles and niosomal formulations for topical application in atopic dermatitis. | |
| The paper does not mention the best cream to incorporate polymeric nanocapsules for atopic dermatitis. | |
5 Citations | The paper does not mention the best cream to incorporate polymeric nanocapsules for atopic dermatitis. The paper focuses on the characterization and evaluation of tacrolimus-loaded poly(ε-caprolactone) nanocapsules for the management of atopic dermatitis. |
| The provided paper does not mention the best cream to incorporate polymeric nanocapsules for atopic dermatitis. | |
| The paper does not mention the best cream to incorporate polymeric nanocapsules for atopic dermatitis. The paper focuses on the use of polymeric nanoparticles for targeted drug delivery in atopic dermatitis lesions. |
Related Questions
What are the products for treatment of atopic dermatitis?5 answersThe products approved for the treatment of atopic dermatitis include subcutaneously injected IL-13 antagonist tralokinumab-ldrm, oral Janus kinase (JAK) inhibitors abrocitinib and upadacitinib. Additionally, difamilast, a phosphodiesterase 4 inhibitor, has shown effectiveness and tolerability in adult and pediatric patients with AD, with rapid onset of action and significant differences from the vehicle within 1 week of treatment. Furthermore, systemic therapies like dupilumab, a monoclonal antibody targeting the IL-4 receptor α subunit, have been approved for moderate-to-severe AD, along with other novel therapies targeting key cytokines like IL-4 and IL-13 or the Janus kinase signaling pathway. Abrocitinib, a JAK inhibitor, is also highlighted as a new treatment option for moderate to severe atopic dermatitis in adults and adolescents. These treatments offer a range of options for managing the complex and chronic nature of atopic dermatitis.
What are the products for treatment of atopic dermatitis in domestic animals?5 answersVarious products have been developed for the treatment of atopic dermatitis (AD) in domestic animals. These include a novel collar containing a lipid extract (LE) for canine atopic dermatitis (CAD), lokivetmab combined with topical products containing plant extracts for atopic dermatitis in dogs, allergen immunotherapy (AIT) through intralymphatic injections (ILIT) or rush immunotherapy (RIT) for AD in dogs, a topical treatment with sphingolipids and glycosaminoglycans (GAGs) extracts for AD in dogs, and topical therapies like shampoos and spot-ons for AD in dogs. These products aim to improve skin health, manage clinical symptoms, repair skin barrier defects, and enhance treatment efficacy, providing veterinarians with a range of options to address the complex nature of atopic dermatitis in domestic animals.
Explain polymeric nanoencapsules as a recent advancements in nanoencapsulation for flavor delivery?4 answersPolymeric nanoencapsules have emerged as a recent advancement in nanoencapsulation for flavor delivery. These nanocarriers, formulated with biopolymers or lipids, offer improved solubility, stability, and bioavailability of natural compounds and plant extracts. Polymeric nanoparticles, in particular, have been reported to efficiently deliver natural bioactive agents with good entrapment potential, controlled release, and enhanced therapeutic efficacy. The use of polymeric nanoparticles for encapsulating natural bioactive agents overcomes the limitations of poor aqueous solubility, low bioavailability, and short duration of action. Additionally, surface decoration and polymer functionalization techniques have been employed to enhance the characteristics of polymeric nanoparticles and mitigate toxicity concerns. These polymeric nanoencapsules have shown promise in the food industry for controlling the release of flavors under different conditions and during cooking. They also have potential applications in the nutraceutical and pharmaceutical sectors.
What are the different types of nanoparticles used in sunscreen formulations?3 answersNanoparticles used in sunscreen formulations include lipid nanoparticles such as solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC). Other types of nanoparticles used in sunscreens are liposomes, ethosomes, microemulsions, nano-emulgel, nano-transferosomes, and niosomes. Additionally, colloidal lignin nanoparticles (cLNPs) have been used in eco-friendly sunscreen formulations. Nanosunscreens often utilize titanium dioxide (TiO2) and zinc oxide (ZnO) nanoparticles as physical blockers. Studies have been conducted to assess the safety and effectiveness of these nanoparticles, including investigations of potential genotoxicity, cytotoxicity, penetration, skin irritation, and toxicity.
What are the adjuvant therapy for Atopic Dermatitis?5 answersAdjuvant therapies for Atopic Dermatitis (AD) include intravenous immunoglobulin (IVIG) therapy. Other non-biologic targeted therapies, such as Janus kinase (JAK) inhibitors and phosphodiesterase 4 (PDE4) inhibitors, have also emerged as treatment options. Evidence-based complementary and alternative medicine (CAM) therapies can be integrated with conventional therapies to augment response in appropriate cases. Conventional treatments for AD include topical corticosteroids, emollients, and topical and/or systemic immunomodulators. New drugs on the horizon promise a previously unimagined potential for effective and safe treatment of AD.
What is the therapeutic potential of nanoparticles loaded with chemotherapeutic agents for the treatment of skin cancer?5 answersNanoparticles loaded with chemotherapeutic agents have shown promising therapeutic potential for the treatment of skin cancer. These nanoparticles can specifically target cancer cells while minimizing adverse effects on healthy cells. Different types of nanoparticles, such as solid lipid nanoparticles (SLNs) and chitosan nanoparticles (CSNPs), have been investigated for their ability to deliver chemotherapeutic drugs effectively. SLNs have been developed and tested for the treatment of skin melanoma, demonstrating improved drug retention over the skin and minimal side effects. CSNPs, on the other hand, have been explored as a pH-responsive drug delivery system, allowing for targeted drug release within the cancer microenvironment. Metallic nanoparticles (MNPs) have also been utilized as drug carriers for skin cancer treatment, offering advantages such as biodegradability, high drug payload, and low toxicity. Overall, the use of nanoparticles loaded with chemotherapeutic agents holds great promise for enhancing the efficacy and reducing the side effects of skin cancer treatment.